These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 37629560)
1. The Role of Plant-Derived Natural Products in the Management of Inflammatory Bowel Disease-What Is the Clinical Evidence So Far? Davila MM; Papada E Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629560 [TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
3. Herbal and plant therapy in patients with inflammatory bowel disease. Triantafyllidi A; Xanthos T; Papalois A; Triantafillidis JK Ann Gastroenterol; 2015; 28(2):210-220. PubMed ID: 25830661 [TBL] [Abstract][Full Text] [Related]
4. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Karthikeyan A; Young KN; Moniruzzaman M; Beyene AM; Do K; Kalaiselvi S; Min T Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918207 [TBL] [Abstract][Full Text] [Related]
5. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice. Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980 [TBL] [Abstract][Full Text] [Related]
6. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease. Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z Front Immunol; 2022; 13():921546. PubMed ID: 35860271 [TBL] [Abstract][Full Text] [Related]
7. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization. Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382 [TBL] [Abstract][Full Text] [Related]
8. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease. Pavel FM; Vesa CM; Gheorghe G; Diaconu CC; Stoicescu M; Munteanu MA; Babes EE; Tit DM; Toma MM; Bungau S Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34203609 [TBL] [Abstract][Full Text] [Related]
9. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. Langhorst J; Wulfert H; Lauche R; Klose P; Cramer H; Dobos GJ; Korzenik J J Crohns Colitis; 2015 Jan; 9(1):86-106. PubMed ID: 25518050 [TBL] [Abstract][Full Text] [Related]
10. The Potential of Natural Oils to Improve Inflammatory Bowel Disease. Zhou Y; Wang D; Duan H; Zhou S; Guo J; Yan W Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299569 [TBL] [Abstract][Full Text] [Related]
11. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy. Cao F; Liu J; Sha BX; Pan HF Curr Pharm Des; 2019; 25(46):4893-4913. PubMed ID: 31840596 [TBL] [Abstract][Full Text] [Related]
12. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Pu D; Zhang Z; Feng B Front Pharmacol; 2022; 13():906419. PubMed ID: 35734396 [TBL] [Abstract][Full Text] [Related]
13. Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease? Gilroy L; Allen PB Clin Exp Gastroenterol; 2014; 7():163-72. PubMed ID: 24899819 [TBL] [Abstract][Full Text] [Related]
14. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations. Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338 [TBL] [Abstract][Full Text] [Related]
15. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota. He X; Liu J; Long G; Xia XH; Liu M Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623 [TBL] [Abstract][Full Text] [Related]
16. Medical therapy of inflammatory bowel disease for the 21st century. Robinson M Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372 [TBL] [Abstract][Full Text] [Related]
17. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease. Guo BJ; Bian ZX; Qiu HC; Wang YT; Wang Y Ann N Y Acad Sci; 2017 Aug; 1401(1):37-48. PubMed ID: 28891095 [TBL] [Abstract][Full Text] [Related]
19. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments. Zhou Y; Wang D; Yan W Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839389 [TBL] [Abstract][Full Text] [Related]
20. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Khan I; Ullah N; Zha L; Bai Y; Khan A; Zhao T; Che T; Zhang C Pathogens; 2019 Aug; 8(3):. PubMed ID: 31412603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]